Society of Family Planning committee consensus on Rh testing in early pregnancy.

Abstract

Historical evidence that fetal red blood cell (RBC) exposure during early spontaneous or induced abortion can cause maternal Rh sensitization is limited. A close reading of these studies indicates that forgoing Rh immunoglobulin administration before 12weeks gestation is highly unlikely to increase risk of Rh (D) antibody development, and recent studies indicate that fetal RBC exposure during aspiration abortion <12 weeks gestation is below the calculated threshold to cause maternal Rh sensitization, and the amount of fetomaternal hemorrhage during dilation and evacuation procedures up to 18weeks gestation is adequately treated with 100mcg of Rh immunoglobulin. We provide updated recommendations for Rh immunoglobulin administration based on this new evidence.

• Authors: Sarah Horvath, Vinita Goyal, Sarah Traxler, Sarah Prager
• Journal: Contraception (Contraception) Vol. 114 Pg. 1-5 (10 2022) ISSN: 1879-0518 [Electronic] United States
• PMID: 35872236 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2022. Published by Elsevier Inc.

Chemical References

• Immunoglobulins
• Rho(D) Immune Globulin

Topics

• Consensus
• Family Planning Services
• Female
• Humans
• Immunoglobulins
• Pregnancy
• Rh Isoimmunization (prevention & control)
• Rho(D) Immune Globulin